Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-077082
Filing Date
2014-11-05
Accepted
2014-11-05 16:30:54
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19712_110q.htm 10-Q 1105357
2 EX-10.1 a14-19712_1ex10d1.htm EX-10.1 390243
3 EX-31.1 a14-19712_1ex31d1.htm EX-31.1 12330
4 EX-31.2 a14-19712_1ex31d2.htm EX-31.2 12352
5 EX-32.1 a14-19712_1ex32d1.htm EX-32.1 5462
6 EX-32.2 a14-19712_1ex32d2.htm EX-32.2 5506
13 GRAPHIC g197121ke05i001.jpg GRAPHIC 3140
14 GRAPHIC g197121ke05i002.jpg GRAPHIC 2318
  Complete submission text file 0001104659-14-077082.txt   6964286

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gern-20140930.xml EX-101.INS 1248998
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20140930.xsd EX-101.SCH 25596
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20140930_cal.xml EX-101.CAL 36115
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20140930_def.xml EX-101.DEF 87734
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gern-20140930_lab.xml EX-101.LAB 296036
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20140930_pre.xml EX-101.PRE 193418
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 141197325
SIC: 2834 Pharmaceutical Preparations